Teradyne Q4 Adj EPS $0.79 Beats $0.71 Estimate, Sales $670.60M Miss $674.66M Estimate
Portfolio Pulse from Benzinga Newsdesk
Teradyne reported Q4 adjusted EPS of $0.79, surpassing the $0.71 estimate, but sales of $670.60M fell short of the expected $674.66M. This reflects an earnings decrease of 14.13% and a sales decrease of 8.37% compared to the same period last year.
January 30, 2024 | 10:15 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Teradyne's Q4 earnings beat estimates but revenue fell short, with both earnings and sales down from the previous year.
While Teradyne beat EPS estimates, the revenue miss and year-over-year declines in both earnings and sales may lead to mixed investor sentiment. The EPS beat could be seen as a positive, but the revenue miss and declines suggest potential underlying challenges. This mixed outcome is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100